InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Rowe Michael M, Chief Operating Officer. Director active across 1 companies, notably Eyenovia, INC.. Aggregated, 6 filings have been recorded. Total volume traded: €31k. The latest transaction was disclosed on 27 October 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€4,2831,200 shares@ €3.568928.0% of flow
Common Stock, par value $.0001
SEC:0001415889-21-004985·
Ideal exit: 24 Jul 2022 (T+270)
€4,2831,200 shares@ €3.568914.0% of flow
Common Stock, par value $.0001
SEC:0001415889-21-004985:0·
Ideal exit: 24 Jul 2022 (T+270)
€5,5881,500 shares@ €3.72536.6% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000708·
Ideal exit: 10 Jun 2022 (T+270)
€5,5881,500 shares@ €3.72518.3% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000708:0·
Ideal exit: 10 Jun 2022 (T+270)
€5,4081,400 shares@ €3.862835.4% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000472·
Ideal exit: 21 Feb 2022 (T+270)
€5,4081,400 shares@ €3.862817.7% of flow
Common Stock, par value $.0001
SEC:0001638599-21-000472:0·
Ideal exit: 21 Feb 2022 (T+270)
6 of 6 declarations
About Rowe Michael M
Michael M. Rowe is the Chief Operating Officer at Eyenovia, Inc. He oversees the daily operations of the company, ensuring efficiency and achievement of strategic objectives. His expertise in the biopharmaceutical sector is crucial for developing new therapies.
